Zydus Cadila gets EIR from USFDA for Ankleshwar facility

The company's active pharmaceutical ingredient (API) manufacturing facility located at Ankleshwar (unit 1), Gujarat has received an Establishment Inspection Report (EIR).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2IlaOpz
via IFTTT